155 related articles for article (PubMed ID: 6772366)
21. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
22. Sexual dysfunction in women during dialysis and after renal transplantation.
Filocamo MT; Zanazzi M; Li Marzi V; Lombardi G; Del Popolo G; Mancini G; Salvadori M; Nicita G
J Sex Med; 2009 Nov; 6(11):3125-31. PubMed ID: 19627463
[TBL] [Abstract][Full Text] [Related]
23. RenaGel efficacy in severe secondary hyperparathyroidism.
Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
[TBL] [Abstract][Full Text] [Related]
24. [Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?].
Noldus J; Huland H
Urologe A; 1994 Jan; 33(1):73-5. PubMed ID: 8146936
[TBL] [Abstract][Full Text] [Related]
25. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
26. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
Hida M
Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
[TBL] [Abstract][Full Text] [Related]
27. The effect of sirolimus on sex hormone levels of male renal transplant recipients.
Lee S; Coco M; Greenstein SM; Schechner RS; Tellis VA; Glicklich DG
Clin Transplant; 2005 Apr; 19(2):162-7. PubMed ID: 15740550
[TBL] [Abstract][Full Text] [Related]
28. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients.
Liou HH; Chiang SS; Huang TP; Shieh SD; Akmal M
Miner Electrolyte Metab; 1994; 20(3):97-102. PubMed ID: 7816008
[TBL] [Abstract][Full Text] [Related]
29. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
Kiilerich S; Christiansen C; Christensen MS; Naestoft J
Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
[TBL] [Abstract][Full Text] [Related]
30. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
31. Does erythropoietin cause hormonal changes in haemodialysis patients?
Steffensen G; Aunsholt NA
Nephrol Dial Transplant; 1993; 8(11):1215-8. PubMed ID: 8302458
[TBL] [Abstract][Full Text] [Related]
32. Hormones and sexuality during transition to menopause.
Gracia CR; Freeman EW; Sammel MD; Lin H; Mogul M
Obstet Gynecol; 2007 Apr; 109(4):831-40. PubMed ID: 17400843
[TBL] [Abstract][Full Text] [Related]
33. Hormonal profile and serum zinc levels in uraemic men with gonadal dysfunction undergoing haemodialysis.
Joven J; Villabona C; Rubiés-Prat J; Espinel E; Galard R
Clin Chim Acta; 1985 Jun; 148(3):239-45. PubMed ID: 3930099
[TBL] [Abstract][Full Text] [Related]
34. [Sexual disorders among men with myotonic dystrophy].
Zaĭlialov DZ; Vasil'chenko GS; Magzhanov RV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):339-42. PubMed ID: 3085415
[TBL] [Abstract][Full Text] [Related]
35. Gonadal function in male patients on maintenance hemodialysis, chronic hepatitis B virus carriers.
Stefanović V; Bogicević M; Ilić S
Acta Med Iugosl; 1988; 42(5):383-9. PubMed ID: 3149855
[No Abstract] [Full Text] [Related]
36. Sexual function in women receiving maintenance dialysis.
Seethala S; Hess R; Bossola M; Unruh ML; Weisbord SD
Hemodial Int; 2010 Jan; 14(1):55-60. PubMed ID: 19758295
[TBL] [Abstract][Full Text] [Related]
37. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
Berl T; Berns AS; Huffer WE; Alfrey AC; Arnaud CD; Schrier RR
Contrib Nephrol; 1980; 18():72-81. PubMed ID: 6243528
[TBL] [Abstract][Full Text] [Related]
38. Blood levels of gonadotropins and gonadal hormones in gynecomastia associated with chronic hemodialysis.
Sawin CT; Longcope C; Schmitt GW; Ryan RJ
J Clin Endocrinol Metab; 1973 May; 36(5):988-90. PubMed ID: 4698251
[No Abstract] [Full Text] [Related]
39. Hemodialysis patients with a unique mineralizing defect unresponsive to 1,25-dihydroxycholecalciferol. Dialysis osteomalacic syndrome.
Cameron EC; Prior JC; Ballon HS
Contrib Nephrol; 1980; 18():162-71. PubMed ID: 6986229
[TBL] [Abstract][Full Text] [Related]
40. 1,25-Dihydroxycholecalciferol in dialysed patients with clinically asymptomatic renal osteodystrophy. A controlled study.
Fischer JA; Binswanger U
Contrib Nephrol; 1980; 18():82-91. PubMed ID: 7353381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
